Category Archives: Uncategorized

Using Genomic Analyses in High Value Situations [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, the last panel of the conference focused on uses for genomics in “high value” settings, including a further focus on uses in cancer cluster cases and medical monitoring cases. Panelists discussed by genomics may represent the best defense in a cancer cluster case, and Kirk Hartley provided a […]

Graphical Illustration of the Difference Between Genetic Susceptibility and Predisposition [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, one of the panels focused primarily on communicating genomic issues to juries and judges, including extensive slides and comments from Magna Legal on communicating the concepts of genetic predisposition and “susceptibility” to cancer, where the defense often seeks to make genetic predisposition arguments and plaintiffs often […]

Genomic Causation Analyses for Claims Involving Environmental Pollution, Pathogen Tracking and Cancer Clusters [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, panelists presented examples of results in “environmental cases” in which genomic analyses was used to provide objective evidence to trace sources of exposure and dispersal, and uses of genomic analyses for cancer cluster cases. The panel provided the perspective that genomics are well-suited to the injuries […]

The Process of Using Genomic Analysis in Cases AKA: The nuts and bolts of processes, time and costs [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, Michael Zapata III and Leonel van Zyl, PhD provided an in depth review and analysis of the nuts and bolts for using genomic analysis in legal cases. Michael and Dr. van Zyl explained their systematic and gated methodology for helping clients considering whether a genomic approach […]

Use of Genomics in Medical Cases (Birth Defects, Malpractice, Drugs) [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, panelists addressed the use of genomics in medical cases (birth defects, malpractice, drugs). The panel was composed of an attorney, a medical doctor, and a genetic scientist. Dr. van Zyl, the genetic scientist, provided insightful information as to why individual genetic variability matters, including for Absorption, […]

biosensor

Webinar: Legal and Policy Considerations in the Use of New Approach Methodologies in Chemical Risk Assessment, Kirk Hartley Presents at ASCCT [Download Presentation]

On Tuesday April 27, Kirk Hartley of ToxicoGenomica presented a webinar hosted by the American Society for Cellular and Computational Toxicology (ASCCT). The topic was: Legal and Policy Considerations in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment. A recording of the webinar can be accessed here and a complimentary copy of […]

WEBINAR ANNOUNCEMENT: What’s in Those Genes?

Genetic Evidence Concerning Causation for Mesothelioma 16 June 2020 at 2pm Eastern Daylight Time. Click Here For More Information and to Register The use of genomics in personal injury cases continues to accelerate, especially including mesothelioma cases. A panel of five speakers will present defense views, plaintiff views, legal rulings, and science on the use […]

Genomic Evidence Essential to Asbestos and Talc Cases: Dr. Len van Zyl Presents at Perrin National Conference

On September 9, Dr. Len van Zyl of ToxicoGenomica presented at Perrin Conferences’ National Asbestos Litigation Conference at the Fairmont San Francisco Hotel. The conference was greatly attended, and attendees were provided with key information on the trends that are currently driving asbestos litigation and the impact these trends may have on future cases. Dr. […]